Literature DB >> 21533719

Consultation-liaison psychiatry for patients with headaches.

O Gambini1, V Barbieri, B Biagianti, S Scarone.   

Abstract

Screening of headache patients for psychiatric disorders is needed, because of the well-known high rates of comorbidity with depression and anxiety. Screening for both depression and anxiety is highly advisable in order to identify subjects who need psychiatric consultation and therapy. Screening tools for depression and anxiety range from informal questions to self-report instruments to structured interviews and the choice is up to the clinician and the setting of the clinical evaluation. Data on psychiatric disorders and medication overuse are till now not consistent. The treatment of mood and anxiety disorders in headache patients needs to take into account the possible drug interactions with headache therapies. The collaboration between neurologists and consultation-liaison psychiatrists helps the identification of headache patients who need a psychiatric therapeutic program and follow-up.

Entities:  

Mesh:

Year:  2011        PMID: 21533719     DOI: 10.1007/s10072-011-0533-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  13 in total

1.  Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance.

Authors:  Alvin E Lake; Jeanetta C Rains; Donald B Penzien; Gay L Lipchik
Journal:  Headache       Date:  2005-05       Impact factor: 5.887

Review 2.  Chronic headaches and the neurobiology of somatization.

Authors:  Jonathan M Borkum
Journal:  Curr Pain Headache Rep       Date:  2010-02

3.  The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.

Authors:  Randolph W Evans; Stewart J Tepper; Robert E Shapiro; Christina Sun-Edelstein; Gretchen E Tietjen
Journal:  Headache       Date:  2010-06       Impact factor: 5.887

Review 4.  A review of screening tools for psychiatric comorbidity in headache patients.

Authors:  Morris Maizels; Todd A Smitherman; Donald B Penzien
Journal:  Headache       Date:  2006-10       Impact factor: 5.887

Review 5.  Pharmacological management of mood and anxiety disorders in headache patients.

Authors:  James L Griffith; Maryam Razavi
Journal:  Headache       Date:  2006-10       Impact factor: 5.887

Review 6.  Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted?

Authors:  Richard G Wenzel; Stewart Tepper; William E Korab; Fredrick Freitag
Journal:  Ann Pharmacother       Date:  2008-10-28       Impact factor: 3.154

Review 7.  SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing?

Authors:  Susanne O Dalton; Henrik T Sørensen; Christoffer Johansen
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

8.  Physical and mental comorbidity of headache in a nationally representative sample of US adults.

Authors:  Amanda Kalaydjian; Kathleen Merikangas
Journal:  Psychosom Med       Date:  2008-08-25       Impact factor: 4.312

Review 9.  Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk.

Authors:  Maurizio Pompili; Daniela Di Cosimo; Marco Innamorati; David Lester; Roberto Tatarelli; Paolo Martelletti
Journal:  J Headache Pain       Date:  2009-06-25       Impact factor: 7.277

10.  Headache, anxiety and depressive disorders: the HADAS study.

Authors:  Ettore Beghi; Gennaro Bussone; Domenico D'Amico; Pietro Cortelli; Sabina Cevoli; Gian Camillo Manzoni; Paola Torelli; Maria Clara Tonini; Giovanni Allais; Roberto De Simone; Florindo D'Onofrio; Sergio Genco; Franca Moschiano; Massimiliano Beghi; Sara Salvi
Journal:  J Headache Pain       Date:  2010-01-27       Impact factor: 7.277

View more
  1 in total

1.  Screening for depression and anxiety disorder in children with headache.

Authors:  Sang Mi Lee; Jung-Rim Yoon; Yoon Young Yi; Soyong Eom; Joon Soo Lee; Heung Dong Kim; Keun-Ah Cheon; Hoon-Chul Kang
Journal:  Korean J Pediatr       Date:  2015-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.